Acute hyperglycaemic crisis after vaccination against COVID-19: A case series

Vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are the most important component of the global response to the COVID-19 pandemic. Although most adverse reactions observed have been mild, the emergence of more serious vaccine-associated adverse events is being closely monitored.